Publications by authors named "Kathleen S Martin"
Background: The early phase of the COVID-19 pandemic led to significant healthcare avoidance, perhaps explaining some of the excess reported deaths that exceeded known infections. The impact of the early COVID-19 era on aneurysmal subarachnoid hemorrhage (aSAH) care remains unclear.
Objective: To determine the impact of the early phase of the COVID-19 pandemic on latency to presentation, neurological complications, and clinical outcomes after aSAH.
Objective: Cerebral vasospasm and delayed cerebral ischemia (DCI) contribute to poor outcome following subarachnoid hemorrhage (SAH). With the paucity of effective treatments, the authors describe their experience with intrathecal (IT) nicardipine for this indication.
Methods: Patients admitted to the Emory University Hospital neuroscience ICU between 2012 and 2017 with nontraumatic SAH, either aneurysmal or idiopathic, were included in the analysis.
Article Synopsis
- * Out of 1,267 patients studied, 16.7% developed AKI, with higher rates of diabetes and hypertension observed in these patients, as well as increased creatinine levels and higher mortality rates (28.3% vs 6.1%).
- * Key risk factors for AKI included male gender, hypertension, diabetes, abnormal baseline creatinine, and increased serum chloride; most patients (78.8%) experienced kidney recovery, significantly lowering mortality for those
Objectives: To identify compounding practices of independent community pharmacy practitioners in order to make recommendations for the development of curricular objectives for doctor of pharmacy (PharmD) programs.
Methods: Independent community practitioners were asked about compounding regarding their motivations, common activities, educational exposures, and recommendations for PharmD education.
Results: Most respondents (69%) accepted compounding as a component of pharmaceutical care and compounded dermatological preparations for local effects, oral solutions, and suspensions at least once a week.
Prevalence of compounding in independent community pharmacy practice.
J Am Pharm Assoc (2003)
November 2006
Objectives: To determine the extent of prescription compounding in independent community pharmacies and identify factors that influence the decision of independent pharmacists whether to provide compounding services.
Design: Cross-sectional survey.
Setting: Illinois, Missouri, Kansas, and Iowa.